Jessica Fife's questions to Crinetics Pharmaceuticals Inc (CRNX) leadership • Q2 2025
Question
An analyst on behalf of Jessica Fife of JPMorgan Chase & Co. asked about the company's comfort level with current consensus sales estimates for the upcoming paltusotine launch.
Answer
CFO Tobin Schilke stated that it is not typical or prudent for the company to comment on consensus estimates at this stage, as they have not provided official guidance. He reiterated confidence in the launch preparations and the progress being made with the FDA.